Clinical trial · Observational
Air-in-Line Alarms During Antineoplastic Drug Infusion
Innovation in Antineoplastic Drug Infusion: A Multiphase Observational Study of Air-in-Line Alarms, Safety, and Therapeutic Continuity
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to evaluate infusion alarms, particularly air-in-line alarms, during antineoplastic drug infusion in oncology care settings. The main questions it aims to answer are: How frequently do infusion alarms occur, and what types of alarms are observed during antineoplastic drug infusion? How long does it take healthcare professionals to manage infusion alarms and restore infusion continuity? What strategies do healthcare professionals use to manage infusion alarms? How do healthcare professionals evaluate the user experience of different infusion technologies? Participants will be healthcare professionals involved in antineoplastic drug infusion. They will not receive any experimental intervention. Researchers will observe routine infusion procedures and collect data on alarm events, alarm management, infusion technologies, and user experience.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Air-in-Line Alarm | — | UNRESOLVED | — |
| Antineoplastic Drug Administration | — | UNRESOLVED | — |
| Infusion Safety | — | UNRESOLVED | — |
| Medication Safety | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Routine Infusion Technologies | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Healthcare Professionals Involved in Antineoplastic Drug Infusion
- description
- Healthcare professionals involved in routine antineoplastic drug infusion procedures in participating oncology centers. Participants will be observed during routine clinical practice to evaluate infusion alarms, alarm management strategies, infusion safety practices, and user experience with infusion technologies.
- interventionNames
- Other: Routine Infusion Technologies
Primary outcomes (1)
- measure
- Frequency and Type of Infusion Alarms
- timeFrame
- Up to 24 months
- description
- Number and type of infusion alarms, including air-in-line alarms, recorded during simulated and real-world antineoplastic infusion procedures.
Secondary outcomes (6)
- measure
- Adherence to Evidence-Based Infusion Safety Practices
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Healthcare professionals involved in the administration of antineoplastic drugs in participating oncology centres. * Employment in a participating study site during the study period. * Direct involvement in routine intravenous antineoplastic drug infusion procedures. * Participation in infusion procedures eligible for observation according to the study protocol. Exclusion Criteria: * Healthcare professionals not directly involved in antineoplastic drug administration. * Healthcare professionals working outside participating study sites. * Temporary staff not routinely involved in infusion activities during the observation period. * Refusal to participate in study activities where local regulations require participant notification.
References
Publications (0)
Data not yet available